Skip to main content

Table 1 Selected characteristics of enrolled subjects in this study

From: Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure

  ATV/r (n = 21) LPV/r (n = 20) P value
Sex (M/F) 21/0 20/0  
Age: median, range (years) 33.5, 21-45 35, 22-57 0.53
CD4 cell count at baseline: median, range (per μgL) 132, 25-367 121, 18-340 0.37
Plasma HIV RNA at baseline: median, range (copies/mL) 35200, 7500-232000 28900, 3500-356000 0.42
CD4 cell count at virological failure: median, range (per μgL) 195, 37-468 202, 65-520 0.56
Plasma HIV RNA at virological failure: median, range (copies/mL) 26500, 1500-87300 22500, 2200-67200 0.37
History of AIDS: no. (%) 14 (67) 15 (75) 0.808
Experienced to NNRTI: no. (%) 12 (57) 13 (65) 0.845
Duration of PI exposure: median, range (months) 13.2, 4.8-18 11.3, 3.5-17 0.32
\